Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease

[1]  C. Jack,et al.  Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype , 2008, Neurology.

[2]  H. Arai,et al.  Concurrence of TDP-43, tau and α-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies , 2007, Brain Research.

[3]  David A. Bennett,et al.  Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.

[4]  J. Trojanowski,et al.  Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam , 2007, Acta Neuropathologica.

[5]  John L. Robinson,et al.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases , 2007, Acta Neuropathologica.

[6]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[7]  D. Dickson,et al.  TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.

[8]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[9]  J. Trojanowski,et al.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.

[10]  Martin Rossor,et al.  Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. , 2006, Archives of neurology.

[11]  Julie S. Snowden,et al.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.

[12]  Dennis W. Dickson,et al.  Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of &agr;-Synucleinopathy , 2006, Journal of neuropathology and experimental neurology.

[13]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[14]  D. Dickson,et al.  Ubiquitin Immunohistochemistry of Frontotemporal Lobar Degeneration Differentiates Cases With and Without Motor Neuron Disease , 2005, Alzheimer disease and associated disorders.

[15]  J. Kril,et al.  Clinicopathological Staging of Frontotemporal Dementia Severity: Correlation with Regional Atrophy , 2004, Dementia and Geriatric Cognitive Disorders.

[16]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[17]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[18]  Martin Rossor,et al.  Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. , 2002, Neurology.

[19]  T. Iwaki,et al.  Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum , 2001, Acta Neuropathologica.

[20]  B. Sahakian,et al.  Differing patterns of temporal atrophy in Alzheimer’s disease and semantic dementia , 2001, Neurology.

[21]  M N Rossor,et al.  Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease , 2001, Annals of neurology.

[22]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[23]  N. Cairns,et al.  Involvement of the amygdala, dentate and hippocampus in motor neuron disease , 1995, Journal of the Neurological Sciences.

[24]  D. Neary,et al.  Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.

[25]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[26]  Y. Mitsuyama.  Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[27]  K Kosaka,et al.  Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? , 1984, Clinical neuropathology.

[28]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.